Description overdue on 14.09.2011

International name of the drug - naphazoline . It refers to a group alpha-adrenergic agonists , Has a decongestant, vasoconstrictor effect. Available in the form nasal drops   or metered nasal spray . Naphthyzinum provide quick, sustained and marked narrowing of blood vessels in the nasal mucosa, reduces swelling, reduces exudation . hyperemia . Regular use of the drug for a week leads to the development of tolerance.

Indications:

Sinusitis , Acute rhinitis, laryngitis , Evstahiit, nasal allergy , Laryngeal edema as a result of irradiation, allergies , Chronic conjunctivitis. Naphthyzinum applied in order to facilitate the procedure rinoskopii To nose bleeding stopped, and as an aid in bacterial conjunctivitis genesis.

Contraindications:

Naphthyzinum is contraindicated in case of hypersensitivity to naphazoline, atherosclerosis, hypertension, hyperthyroidism, diabetes mellitus, severe eye disease, chronic rhinitis. Contraindications acts and concomitant use of drugs from the group of MAO inhibitors ( monoamine oxidase ), And the period up to 2 weeks to complete their reception.

Side effects:

Perhaps the development of tachycardia, nausea, increased blood pressure, migraine . With regular use naftizina than 1 week may develop atrophic rhinitis, edema of the mucosa of the nasal cavity.

Overdose:

Symptoms: bradycardia . hypothermia . increased blood pressure . Treatment is symptomatic.

Mode of application:

In otorhinolaryngology: adults - 1-3 drops of solution (0, 05-0, 1%) to three isolator day. Babies: the nasal cavity dig 0, 025-0, 05% solution. Children from year to 6 years naftizina recommended dose - 1-2 Cap. Children from 6 to 15 years - up to three times a day 2 drops. For diagnostic purposes after purification of the nasal passages to instill 3-4. When edema, hyperemia vocal cords drug is administered in small doses by means of laryngeal syringe, either in the form of a spray in an amount of 1-2 ml. If bleeding is administered swabs, pre-moistened with 0, 05% aqueous solution. In ophthalmology: into the cavity of of the conjunctiva is administered 1-2 kap. 0 05% solution, up to three times a day. As an additional drug for the purpose of surface anesthesia administered 2-4 cap. per 1 ml of the anesthetic agent.

Special instructions:

The product is able to provide resorptive effects . Tolerated sterilization solution of drug (after removal of the pads, drip valve) at a temperature of 115-116 ° C in a water saturated steam for half an hour. With prolonged use, there is a decrease of severity naftizina vasoconstrictor effect. When using the drug for a week you need to take a break. Naphthyzinum used during pregnancy is allowed, but not recommended. Similarly, women who are breastfeeding.

Connectivity:

The drug reduces the absorption of local anesthetics, resulting in lengthening the period of their exposure at the surface anesthesia. It is not recommended to use simultaneously Naphthyzinum inhibitors and MAO (monoamine oxidase), and 10 days after their reception. Naphthyzinum reduces the effectiveness of antihypertensives , Enhances the effect of sedatives and sleeping pills.

Store at 10-25 ° C, in a dark place, away from children. The drug must be protected from freezing.